
METROPOLIS
NSEPrice History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Price Action
Support & Resistance Levels
Volume Analysis
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹322.8 Cr | ₹345.3 Cr | ₹386.1 Cr | ₹405.9 Cr |
| Net Profit | ₹31.4 Cr | ₹29.1 Cr | ₹45.1 Cr | ₹41.4 Cr |
| EPS | ₹6.12 | — | ₹8.70 | ₹7.99 |
| Operating Profit | ₹74.6 Cr | ₹69.3 Cr | ₹97.3 Cr | ₹94.8 Cr |
Peer Comparison
Healthcare Service ProviderPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| LALPATHLAB | Dr. Lal Path Labs Ltd. | ₹1,601.50 | +0.50% |
| VIJAYA | Vijaya Diagnostic Centre Limited | ₹1,287.20 | +0.63% |
| THYROCARE | Thyrocare Technologies Limited | ₹528.90 | +1.83% |
| NEPHROPLUS | Nephrocare Health Services Limited | ₹748.15 | -0.42% |
| KRSNAA | Krsnaa Diagnostics Limited | ₹534.30 | +0.23% |
| SURAKSHA | Suraksha Diagnostic Limited | ₹268.05 | +0.00% |
| 3BBLACKBIO | 3B Blackbio Dx Limited | ₹1,245.40 | -0.69% |
| HEALTHX | Health X Platform Limited | ₹280.90 | +0.90% |
| CHANDAN | Chandan Healthcare Limited | ₹226.80 | +1.18% |
| INVICTA | Invicta Diagnostic Limited | ₹59.95 | -1.72% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 19 May 2026 | Interim Dividend - Re 1 Per Share | INTERIM_DIVIDEND |
| 20 Mar 2026 | Bonus 3:1 | BONUS |
| 11 Nov 2025 | Interim Dividend - Rs 4 Per Share | INTERIM_DIVIDEND |
| 17 Nov 2023 | Interim Dividend - Rs 4 Per Share | INTERIM_DIVIDEND |
| 10 Aug 2023 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for METROPOLIS
View All
Stocks to buy: Sagar Doshi suggests Bandhan Bank, Metropolis Healthcare, CESC shares to buy - Mint
Stocks to buy: Sagar Doshi suggests Bandhan Bank, Metropolis Healthcare, CESC shares to buyMint

Upcoming dividends, stock splits, buybacks this week: L&T, Havells India, ITC Hotels, Metropolis Healthcare, GM Breweries among others in focus - Upstox
Upcoming dividends, stock splits, buybacks this week: L&T, Havells India, ITC Hotels, Metropolis Healthcare, GM Breweries among others in focusUpstox
Open to 4-5 acquisitions, but at sensible valuations: Ameera Shah, promoter and executive chairperson, Metropolis Healthcare
Metropolis Healthcare is set for its next growth phase. The diagnostic chain will focus on genomics and specialty diagnostics. Strategic acquisitions will also play a key role. The company aims to expand services beyond pathology. This strategy will drive future growth and strengthen its market position.